vs
Side-by-side financial comparison of Lucid Diagnostics Inc. (LUCD) and SOCIETY PASS INCORPORATED. (SOPA). Click either name above to swap in a different company.
SOCIETY PASS INCORPORATED. is the larger business by last-quarter revenue ($1.4M vs $1.2M, roughly 1.1× Lucid Diagnostics Inc.). SOCIETY PASS INCORPORATED. runs the higher net margin — -370.8% vs -858.5%, a 487.7% gap on every dollar of revenue. On growth, Lucid Diagnostics Inc. posted the faster year-over-year revenue change (3.3% vs -17.6%). Over the past eight quarters, Lucid Diagnostics Inc.'s revenue compounded faster (7.9% CAGR vs -11.2%).
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
The Wilderness Society is an Australian, community-based, not-for-profit non-governmental environmental advocacy organisation.
LUCD vs SOPA — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $1.4M |
| Net Profit | $-10.4M | $-5.1M |
| Gross Margin | — | 64.3% |
| Operating Margin | -971.0% | -379.9% |
| Net Margin | -858.5% | -370.8% |
| Revenue YoY | 3.3% | -17.6% |
| Net Profit YoY | 16.0% | -271.5% |
| EPS (diluted) | $-0.10 | $-0.89 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $1.2M | $1.4M | ||
| Q2 25 | $1.2M | $2.5M | ||
| Q1 25 | $828.0K | $1.5M | ||
| Q4 24 | $1.2M | $1.9M | ||
| Q3 24 | $1.2M | $1.7M | ||
| Q2 24 | $976.0K | $1.7M | ||
| Q1 24 | $1.0M | $1.8M | ||
| Q4 23 | $1.0M | $1.7M |
| Q3 25 | $-10.4M | $-5.1M | ||
| Q2 25 | $-4.4M | $479.0K | ||
| Q1 25 | $-26.9M | $-1.8M | ||
| Q4 24 | $-11.5M | $-4.1M | ||
| Q3 24 | $-12.4M | $-1.4M | ||
| Q2 24 | $-11.0M | $-1.9M | ||
| Q1 24 | $-10.6M | $-2.8M | ||
| Q4 23 | $-10.8M | $-5.7M |
| Q3 25 | — | 64.3% | ||
| Q2 25 | — | 56.5% | ||
| Q1 25 | — | 31.6% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | 27.1% | ||
| Q1 24 | — | 26.7% | ||
| Q4 23 | — | 36.8% |
| Q3 25 | -971.0% | -379.9% | ||
| Q2 25 | -978.8% | -6.1% | ||
| Q1 25 | -1508.1% | -126.6% | ||
| Q4 24 | -1033.8% | -165.6% | ||
| Q3 24 | -997.8% | -70.1% | ||
| Q2 24 | -1146.7% | -126.0% | ||
| Q1 24 | -1078.1% | -156.6% | ||
| Q4 23 | -1101.3% | -283.1% |
| Q3 25 | -858.5% | -370.8% | ||
| Q2 25 | -381.7% | 19.1% | ||
| Q1 25 | -3249.8% | -124.9% | ||
| Q4 24 | -964.2% | -217.5% | ||
| Q3 24 | -1055.5% | -82.2% | ||
| Q2 24 | -1127.6% | -113.3% | ||
| Q1 24 | -1060.1% | -153.8% | ||
| Q4 23 | -1041.3% | -323.7% |
| Q3 25 | $-0.10 | $-0.89 | ||
| Q2 25 | $-0.08 | $0.10 | ||
| Q1 25 | $-0.52 | $-0.44 | ||
| Q4 24 | $-0.17 | $-1.03 | ||
| Q3 24 | $-0.25 | $-0.48 | ||
| Q2 24 | $-0.23 | $-0.73 | ||
| Q1 24 | $-0.40 | $-1.21 | ||
| Q4 23 | $-0.25 | $-2.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $25.8M | $13.9M |
| Total Assets | $53.2M | $32.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $47.3M | $6.6M | ||
| Q2 25 | $31.1M | $8.2M | ||
| Q1 25 | $25.2M | $7.1M | ||
| Q4 24 | $22.4M | $7.6M | ||
| Q3 24 | $14.5M | $4.2M | ||
| Q2 24 | $24.9M | $833.9K | ||
| Q1 24 | $24.8M | $1.6M | ||
| Q4 23 | $18.9M | $3.6M |
| Q3 25 | $25.8M | $13.9M | ||
| Q2 25 | $7.9M | $2.4M | ||
| Q1 25 | $-5.4M | $-663.0K | ||
| Q4 24 | $5.4M | $-2.1M | ||
| Q3 24 | $6.3M | $862.6K | ||
| Q2 24 | $16.0M | $2.4M | ||
| Q1 24 | $11.9M | $3.5M | ||
| Q4 23 | $-2.3M | $5.3M |
| Q3 25 | $53.2M | $32.9M | ||
| Q2 25 | $38.7M | $29.2M | ||
| Q1 25 | $32.8M | $22.9M | ||
| Q4 24 | $30.7M | $21.3M | ||
| Q3 24 | $22.6M | $17.0M | ||
| Q2 24 | $34.1M | $13.0M | ||
| Q1 24 | $32.0M | $13.3M | ||
| Q4 23 | $27.3M | $16.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.9M | $-16.7M |
| Free Cash FlowOCF − Capex | — | $-16.7M |
| FCF MarginFCF / Revenue | — | -1211.0% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-10.9M | $-16.7M | ||
| Q2 25 | $-10.5M | $-1.8M | ||
| Q1 25 | $-12.5M | $-4.0M | ||
| Q4 24 | $-9.9M | $3.7M | ||
| Q3 24 | $-10.2M | $2.0M | ||
| Q2 24 | $-11.5M | $-864.6K | ||
| Q1 24 | $-12.6M | $-2.4M | ||
| Q4 23 | $-10.0M | $-4.1M |
| Q3 25 | — | $-16.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $-4.1M |
| Q3 25 | — | -1211.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | -235.8% |
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 1.9% |
| Q3 25 | — | — | ||
| Q2 25 | — | -3.70× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
